[HTML][HTML] The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic
A Shariati, M Arshadi, MA Khosrojerdi… - Frontiers in public …, 2022 - frontiersin.org
For around three decades, the fluoroquinolone (FQ) antibiotic ciprofloxacin has been used
to treat a range of diseases, including chronic otorrhea, endocarditis, lower respiratory tract …
to treat a range of diseases, including chronic otorrhea, endocarditis, lower respiratory tract …
[HTML][HTML] Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic bacteria
RV Sionov, D Steinberg - Microorganisms, 2022 - mdpi.com
Chronic and recurrent bacterial infections are frequently associated with the formation of
biofilms on biotic or abiotic materials that are composed of mono-or multi-species cultures of …
biofilms on biotic or abiotic materials that are composed of mono-or multi-species cultures of …
A microbe-derived efflux pump inhibitor of the resistance-nodulation-cell division protein restores antibiotic susceptibility in Escherichia coli and Pseudomonas …
The use of efflux pump inhibitors (EPIs) as potentiators along with the traditional antibiotics
assists in the warfare against antibiotic-resistant superbugs. Efflux pumps of the resistance …
assists in the warfare against antibiotic-resistant superbugs. Efflux pumps of the resistance …
[HTML][HTML] The Major Facilitator Superfamily and Antimicrobial Resistance Efflux Pumps of the ESKAPEE Pathogen Staphylococcus aureus
The ESKAPEE bacterial pathogen Staphylococcus aureus has posed a serious public
health concern for centuries. Throughout its evolutionary course, S. aureus has developed …
health concern for centuries. Throughout its evolutionary course, S. aureus has developed …
Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors
G Kumar, AK Tudu - Bioorganic & Medicinal Chemistry, 2023 - Elsevier
Staphylococcus aureus (S. aureus) is a pathogen responsible for various community and
hospital-acquired infections with life-threatening complications like bacteraemia …
hospital-acquired infections with life-threatening complications like bacteraemia …
Repurposing approved drugs as fluoroquinolone potentiators to overcome efflux pump resistance in Staphylococcus aureus
Staphylococcus aureus is a versatile human commensal bacteria and pathogen that causes
various community and hospital-acquired infections. The S. aureus efflux pump NorA which …
various community and hospital-acquired infections. The S. aureus efflux pump NorA which …
Efflux pump inhibitory potential of indole derivatives as an arsenal against norA over-expressing Staphylococcus aureus
NorA, an extensively studied efflux pump in Staphylococcus aureus, has been connected to
fluoroquinolone, antiseptic, and disinfection resistance. Several studies have also …
fluoroquinolone, antiseptic, and disinfection resistance. Several studies have also …
The cell–cell communication signal indole controls the physiology and interspecies communication of Acinetobacter baumannii
B Cui, X Chen, Q Guo, S Song, M Wang… - Microbiology …, 2022 - Am Soc Microbiol
Many bacteria utilize quorum sensing (QS) to control group behavior in a cell density-
dependent manner. Previous studies have demonstrated that Acinetobacter baumannii …
dependent manner. Previous studies have demonstrated that Acinetobacter baumannii …
Antifungal azoles as tetracycline resistance modifiers in Staphylococcus aureus
Staphylococcus aureus has developed resistance to antimicrobials since their first use. The
S. aureus major facilitator superfamily (MFS) efflux pump Tet (K) contributes to resistance to …
S. aureus major facilitator superfamily (MFS) efflux pump Tet (K) contributes to resistance to …
[HTML][HTML] Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens
The excessive use of antibiotics has led to the emergence of multidrug-resistant (MDR)
pathogens in clinical settings and food-producing animals, posing significant challenges to …
pathogens in clinical settings and food-producing animals, posing significant challenges to …